The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Andrews Deborah J since 2006.
This trader's CIK number is 1325697.
At the time of last reporting, Andrews Deborah J was the Officer of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | LCTX | 0 | $0 | 19,142 | $56,086 | 24,720 | $54,384 |
| 2018 | LCTX | 1,604 | $3,769 | 0 | $0 | 0 | $0 |
| 2017 | LCTX | 6,396 | $18,300 | 0 | $0 | 0 | $0 |
| 2015 | LCTX | 2,000 | $5,640 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | STAA | 0 | $0 | 107,438 | $4,521,556 | 106,604 | $1,386,918 |
| 2019 | STAA | 0 | $0 | 6,000 | $211,248 | 0 | $0 |
| 2018 | STAA | 0 | $0 | 13,664 | $239,969 | 38,331 | $180,793 |
| 2013 | STAA | 0 | $0 | 113,243 | $1,368,472 | 83,515 | $367,884 |
| 2012 | STAA | 0 | $0 | 0 | $0 | 3,000 | $10,800 |
| 2011 | STAA | 0 | $0 | 30,000 | $197,700 | 0 | $0 |
| 2006 | STAA | 0 | $0 | 6,100 | $41,785 | 13,000 | $54,600 |
1. Lineage Cell Therapeutics, Inc. (LCTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-29 | LCTX | Option Ex | 24,720 | 2.20 | 54,384 |
| 2021-06-29 | LCTX | Sale | 19,142 | 2.93 | 56,086 |
| 2018-09-11 | BTX | Buy | 1,604 | 2.35 | 3,769 |
| 2017-08-21 | BTX | Buy | 2,396 | 2.50 | 5,990 |
| 2017-06-16 | BTX | Buy | 2,000 | 2.95 | 5,900 |
| 2017-05-16 | BTX | Buy | 2,000 | 3.21 | 6,410 |
| 2015-08-26 | BTX | Buy | 2,000 | 2.82 | 5,640 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-03-23 | STAA | Sale | 834 | 27.42 | 22,868 |
| 2020-01-21 | STAA | Option Ex | 106,604 | 13.01 | 1,386,918 |
| 2020-01-21 | STAA | Sale | 106,604 | 42.20 | 4,498,688 |
| 2019-11-14 | STAA | Sale | 4,167 | 34.68 | 144,511 |
| 2019-04-04 | STAA | Sale | 1,000 | 34.35 | 34,350 |
| 2019-03-22 | STAA | Sale | 833 | 38.88 | 32,387 |
| 2018-05-03 | STAA | Option Ex | 13,331 | 2.91 | 38,793 |
| 2018-05-07 | STAA | Option Ex | 25,000 | 5.68 | 142,000 |
| 2018-05-03 | STAA | Sale | 13,331 | 17.60 | 234,625 |
| 2018-03-22 | STAA | Sale | 333 | 16.05 | 5,344 |
| 2013-09-03 | STAA | Option Ex | 39,700 | 4.71 | 186,987 |
| 2013-09-04 | STAA | Option Ex | 10,300 | 4.71 | 48,513 |
| 2013-09-03 | STAA | Sale | 39,700 | 12.95 | 514,273 |
| 2013-09-04 | STAA | Sale | 10,300 | 12.58 | 129,543 |
| 2013-08-20 | STAA | Option Ex | 33,515 | 3.95 | 132,384 |
| 2013-08-20 | STAA | Sale | 33,515 | 11.65 | 390,449 |
| 2013-08-09 | STAA | Sale | 2,443 | 11.60 | 28,338 |
| 2013-08-12 | STAA | Sale | 800 | 11.66 | 9,326 |
| 2013-08-13 | STAA | Sale | 685 | 11.70 | 8,013 |
| 2013-08-12 | STAA | Sale | 800 | 11.66 | 9,326 |
| 2013-08-09 | STAA | Sale | 2,443 | 11.60 | 28,338 |
| 2013-08-08 | STAA | Sale | 5,836 | 11.63 | 67,866 |
| 2013-08-05 | STAA | Sale | 4,700 | 11.91 | 55,958 |
| 2013-08-06 | STAA | Sale | 834 | 11.72 | 9,773 |
| 2013-08-07 | STAA | Sale | 6,187 | 11.71 | 72,449 |
| 2013-05-09 | STAA | Sale | 5,000 | 8.96 | 44,820 |
| 2012-12-07 | STAA | Option Ex | 3,000 | 3.60 | 10,800 |
| 2011-08-18 | STAA | Sale | 30,000 | 6.59 | 197,700 |
| 2006-09-06 | STAA | Option Ex | 13,000 | 4.20 | 54,600 |
| 2006-09-06 | STAA | Sale | 6,100 | 6.85 | 41,785 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Andrews Deborah J (Officer of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.